Literature DB >> 17327246

An introduction to causal modeling in clinical trials.

Scarlett L Bellamy1, Julia Y Lin, Thomas R Ten Have.   

Abstract

PURPOSE: We review and compare two causal modeling approaches that correspond to two major and distinct classes of inference - efficacy and intervention-based inference - in the context of randomized trials with subject noncompliance.
METHODS: We review the definitions of efficacy and intervention-based effects in the clinical trials literature and relate these to two separate and distinct causal modeling approaches: the structural mean modeling (SMM) approach and the principal stratification, instrumental variable approach.
RESULTS: The SMM-based efficacy approach focuses on the effect of actually receiving treatment. In contrast, the principal stratification method addresses the effect of treatment assignment within partially unobserved latent subgroups defined by compliance behavior. While these approaches differ in terms of philosophy, model definitions, and estimation, they estimate the same causal effect under certain assumptions, but estimate very different causal effects when those assumptions are relaxed. We illustrate these results using a randomized psychiatry trial where the focus is physician compliance to the designated protocol and the other examines patient compliance to the designated protocol, both from the same trial. LIMITATIONS: The validity of the models under the instrumental variable, SMM and principal stratification approaches depends on modeling assumptions, some of which may not be verifiable from the observed data and potentially less realistic than the no-confounding assumption made by non-causal approaches.
CONCLUSIONS: This comparison in terms of efficacy versus intervention-based effects in causal modeling parallels the explanatory versus pragmatic approaches in clinical trials research; therefore researchers should weigh carefully when choosing causal modeling methodology based on whether efficacy or intervention-based effects are of interest.

Entities:  

Mesh:

Year:  2007        PMID: 17327246     DOI: 10.1177/1740774506075549

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  22 in total

1.  Injection-related venous disease and walking mobility.

Authors:  Barbara Pieper; Thomas N Templin; Robert S Kirsner; Thomas J Birk
Journal:  J Addict Dis       Date:  2010-10

2.  Mediators, moderators, and modulators of causal effects in clinical trials--Dynamically Modified Outcomes (DYNAMO) in health-related quality of life.

Authors:  Gary W Donaldson; Yoshio Nakamura; Carol Moinpour
Journal:  Qual Life Res       Date:  2009-01-20       Impact factor: 4.147

3.  The role of secondary cytoreductive surgery in patients with recurrent epithelial ovarian, tubal, and peritoneal cancers: a comparative effectiveness analysis.

Authors:  Chi-Mu Chuang; Yiing-Jeng Chou; Ming-Shyen Yen; Kuan-Chong Chao; Nae-Fang Twu; Hua-Hsi Wu; Kuo-Chang Wen; Yi-Jen Chen; Peng-Hui Wang; Chung-Ru Lai; Pesus Chou
Journal:  Oncologist       Date:  2012-05-16

4.  Motivational intervention to reduce rapid subsequent births to adolescent mothers: a community-based randomized trial.

Authors:  Beth Barnet; Jiexin Liu; Margo DeVoe; Anne K Duggan; Melanie A Gold; Edward Pecukonis
Journal:  Ann Fam Med       Date:  2009 Sep-Oct       Impact factor: 5.166

5.  Estimating causal effects from a randomized clinical trial when noncompliance is measured with error.

Authors:  Jeffrey A Boatman; David M Vock; Joseph S Koopmeiners; Eric C Donny
Journal:  Biostatistics       Date:  2018-01-01       Impact factor: 5.899

6.  Adjustment for Variable Adherence Under Hierarchical Structure: Instrumental Variable Modeling Through Compound Residual Inclusion.

Authors:  Tyson H Holmes; Donna M Zulman; Clete A Kushida
Journal:  Med Care       Date:  2016-01-13       Impact factor: 2.983

7.  Longitudinal structural mixed models for the analysis of surgical trials with noncompliance.

Authors:  Colleen M Sitlani; Patrick J Heagerty; Emily A Blood; Tor D Tosteson
Journal:  Stat Med       Date:  2012-02-17       Impact factor: 2.373

8.  A tutorial on principal stratification-based sensitivity analysis: application to smoking cessation studies.

Authors:  Brian L Egleston; Karen L Cropsey; Amy B Lazev; Carolyn J Heckman
Journal:  Clin Trials       Date:  2010-04-27       Impact factor: 2.486

9.  Neuropsychiatric clinical trials: should they accommodate real-world practices or set standards for clinical practices?

Authors:  Robert E Becker; Nigel H Greig
Journal:  J Clin Psychopharmacol       Date:  2009-02       Impact factor: 3.153

10.  Mediation analysis with principal stratification.

Authors:  Robert Gallop; Dylan S Small; Julia Y Lin; Michael R Elliott; Marshall Joffe; Thomas R Ten Have
Journal:  Stat Med       Date:  2009-03-30       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.